Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?

Detalhes bibliográficos
Autor(a) principal: de Melo, Daniela Oliveira [UNIFESP]
Data de Publicação: 2016
Outros Autores: Storpirtis, Silvia, Ribeiro, Eliane
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: https://repositorio.unifesp.br/handle/11600/57565
http://dx.doi.org/10.1590/S1984-82502016000300005
Resumo: The purpose of the work was to assess the incidence of potential drug interactions (pDDI), major pDDI, and the use of potentially inappropriate medication (PIM) at hospital admission, during hospitalization, and at discharge to evaluate whether hospital admission provides an opportunity for improving pharmacotherapy in elderly patients at a University hospital that has a clinical pharmacist. A prospective cohort study was carried out using data from the medical records of patients admitted to an internal medicine ward. All admissions and prescriptions were monitored between March and August 2006. Micromedex (R) DrugReax (R) and Beers Criteria 2015 were used to identify pDDI, major pDDI, and PIMs, respectively. A comparison of admission and discharge prescriptions showed the following: an increase in the proportion of patients using antithrombotic agents (76 versus 144; p< 0.001), lipid modifying agents (58 versus 81; p= 0.024), drugs for acid-related disorders (99 versus 152; p< 0.001), and particularly omeprazole (61 versus 87; p= 0.015); a decrease in the number of patients prescribed psycholeptics (73 versus 32; p< 0.001) and diazepam (54 versus 13; p< 0.001); and a decrease in the proportion of patients exposed to polypharmacy (16.1% versus 10.1%; p= 0.025), at least one pDDI (44.5% versus 32.8%; p= 0.002), major pDDI (19.9% versus 12.2%; p= 0.010) or PIM (85.8% versus 51.9%; p< 0.001). The conclusion is that admission to a hospital ward that has a clinical pharmacist was associated with a reduction in the number of patients exposed to polypharmacy, pDDI, major pDDI, and the use of PIMs among elderly inpatients.
id UFSP_4876c088c9c28576497ffe341f18d416
oai_identifier_str oai:repositorio.unifesp.br:11600/57565
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling de Melo, Daniela Oliveira [UNIFESP]Storpirtis, SilviaRibeiro, Eliane2020-08-14T13:44:16Z2020-08-14T13:44:16Z2016Brazilian Journal Of Pharmaceutical Sciences. Sao Paulo, v. 52, n. 3, p. 391-401, 2016.1984-8250https://repositorio.unifesp.br/handle/11600/57565http://dx.doi.org/10.1590/S1984-82502016000300005WOS000390332400005.pdfS1984-8250201600030039110.1590/S1984-82502016000300005WOS:000390332400005The purpose of the work was to assess the incidence of potential drug interactions (pDDI), major pDDI, and the use of potentially inappropriate medication (PIM) at hospital admission, during hospitalization, and at discharge to evaluate whether hospital admission provides an opportunity for improving pharmacotherapy in elderly patients at a University hospital that has a clinical pharmacist. A prospective cohort study was carried out using data from the medical records of patients admitted to an internal medicine ward. All admissions and prescriptions were monitored between March and August 2006. Micromedex (R) DrugReax (R) and Beers Criteria 2015 were used to identify pDDI, major pDDI, and PIMs, respectively. A comparison of admission and discharge prescriptions showed the following: an increase in the proportion of patients using antithrombotic agents (76 versus 144; p< 0.001), lipid modifying agents (58 versus 81; p= 0.024), drugs for acid-related disorders (99 versus 152; p< 0.001), and particularly omeprazole (61 versus 87; p= 0.015); a decrease in the number of patients prescribed psycholeptics (73 versus 32; p< 0.001) and diazepam (54 versus 13; p< 0.001); and a decrease in the proportion of patients exposed to polypharmacy (16.1% versus 10.1%; p= 0.025), at least one pDDI (44.5% versus 32.8%; p= 0.002), major pDDI (19.9% versus 12.2%; p= 0.010) or PIM (85.8% versus 51.9%; p< 0.001). The conclusion is that admission to a hospital ward that has a clinical pharmacist was associated with a reduction in the number of patients exposed to polypharmacy, pDDI, major pDDI, and the use of PIMs among elderly inpatients.School of Pharmaceutical Sciences and the University Hospital of the University of Sao PauloCoordination for the Improvement of Higher Education Personnel (CAPES)Univ Fed Sao Paulo, Inst Environm Sci Chem & Pharmaceut, Dept Biol Sci, Sao Paulo, BrazilUniv Sao Paulo, Dept Pharm, Coll Pharmaceut Sci, Sao Paulo, BrazilUniv Sao Paulo, Univ Hosp, Sao Paulo, BrazilUniv Fed Sao Paulo, Inst Environm Sci Chem & Pharmaceut, Dept Biol Sci, Sao Paulo, BrazilCAPES: 140956/2006-9Web of Science391-401engUniv Sao Paulo, Conjunto QuimicasBrazilian Journal Of Pharmaceutical SciencesDoes hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleSao Paulo523info:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALWOS000390332400005.pdfWOS000390332400005.pdfapplication/pdf374349${dspace.ui.url}/bitstream/11600/57565/1/WOS000390332400005.pdf36e5d0387c2429fb4cbffb41aee2c2f5MD51open accessTEXTWOS000390332400005.pdf.txtWOS000390332400005.pdf.txtExtracted texttext/plain42915${dspace.ui.url}/bitstream/11600/57565/8/WOS000390332400005.pdf.txt9c6b4e71dc40e0c0325e636ec30c133cMD58open accessTHUMBNAILWOS000390332400005.pdf.jpgWOS000390332400005.pdf.jpgIM Thumbnailimage/jpeg7980${dspace.ui.url}/bitstream/11600/57565/10/WOS000390332400005.pdf.jpg710da2806cd906e2ec3a18dac0475993MD510open access11600/575652023-06-05 19:23:50.47open accessoai:repositorio.unifesp.br:11600/57565Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-06-05T22:23:50Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?
title Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?
spellingShingle Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?
de Melo, Daniela Oliveira [UNIFESP]
title_short Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?
title_full Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?
title_fullStr Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?
title_full_unstemmed Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?
title_sort Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?
author de Melo, Daniela Oliveira [UNIFESP]
author_facet de Melo, Daniela Oliveira [UNIFESP]
Storpirtis, Silvia
Ribeiro, Eliane
author_role author
author2 Storpirtis, Silvia
Ribeiro, Eliane
author2_role author
author
dc.contributor.author.fl_str_mv de Melo, Daniela Oliveira [UNIFESP]
Storpirtis, Silvia
Ribeiro, Eliane
description The purpose of the work was to assess the incidence of potential drug interactions (pDDI), major pDDI, and the use of potentially inappropriate medication (PIM) at hospital admission, during hospitalization, and at discharge to evaluate whether hospital admission provides an opportunity for improving pharmacotherapy in elderly patients at a University hospital that has a clinical pharmacist. A prospective cohort study was carried out using data from the medical records of patients admitted to an internal medicine ward. All admissions and prescriptions were monitored between March and August 2006. Micromedex (R) DrugReax (R) and Beers Criteria 2015 were used to identify pDDI, major pDDI, and PIMs, respectively. A comparison of admission and discharge prescriptions showed the following: an increase in the proportion of patients using antithrombotic agents (76 versus 144; p< 0.001), lipid modifying agents (58 versus 81; p= 0.024), drugs for acid-related disorders (99 versus 152; p< 0.001), and particularly omeprazole (61 versus 87; p= 0.015); a decrease in the number of patients prescribed psycholeptics (73 versus 32; p< 0.001) and diazepam (54 versus 13; p< 0.001); and a decrease in the proportion of patients exposed to polypharmacy (16.1% versus 10.1%; p= 0.025), at least one pDDI (44.5% versus 32.8%; p= 0.002), major pDDI (19.9% versus 12.2%; p= 0.010) or PIM (85.8% versus 51.9%; p< 0.001). The conclusion is that admission to a hospital ward that has a clinical pharmacist was associated with a reduction in the number of patients exposed to polypharmacy, pDDI, major pDDI, and the use of PIMs among elderly inpatients.
publishDate 2016
dc.date.issued.fl_str_mv 2016
dc.date.accessioned.fl_str_mv 2020-08-14T13:44:16Z
dc.date.available.fl_str_mv 2020-08-14T13:44:16Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Brazilian Journal Of Pharmaceutical Sciences. Sao Paulo, v. 52, n. 3, p. 391-401, 2016.
dc.identifier.uri.fl_str_mv https://repositorio.unifesp.br/handle/11600/57565
http://dx.doi.org/10.1590/S1984-82502016000300005
dc.identifier.issn.none.fl_str_mv 1984-8250
dc.identifier.file.none.fl_str_mv WOS000390332400005.pdf
dc.identifier.scielo.none.fl_str_mv S1984-82502016000300391
dc.identifier.doi.none.fl_str_mv 10.1590/S1984-82502016000300005
dc.identifier.wos.none.fl_str_mv WOS:000390332400005
identifier_str_mv Brazilian Journal Of Pharmaceutical Sciences. Sao Paulo, v. 52, n. 3, p. 391-401, 2016.
1984-8250
WOS000390332400005.pdf
S1984-82502016000300391
10.1590/S1984-82502016000300005
WOS:000390332400005
url https://repositorio.unifesp.br/handle/11600/57565
http://dx.doi.org/10.1590/S1984-82502016000300005
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Brazilian Journal Of Pharmaceutical Sciences
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 391-401
dc.coverage.none.fl_str_mv Sao Paulo
dc.publisher.none.fl_str_mv Univ Sao Paulo, Conjunto Quimicas
publisher.none.fl_str_mv Univ Sao Paulo, Conjunto Quimicas
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
bitstream.url.fl_str_mv ${dspace.ui.url}/bitstream/11600/57565/1/WOS000390332400005.pdf
${dspace.ui.url}/bitstream/11600/57565/8/WOS000390332400005.pdf.txt
${dspace.ui.url}/bitstream/11600/57565/10/WOS000390332400005.pdf.jpg
bitstream.checksum.fl_str_mv 36e5d0387c2429fb4cbffb41aee2c2f5
9c6b4e71dc40e0c0325e636ec30c133c
710da2806cd906e2ec3a18dac0475993
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764181173174272